Clinical Drug Development Online MSc at Queen Mary University of London

GBP 12,850

Queen Mary University of London, GBR

Type: Masters Duration: 1.0 years

Explore the Clinical Drug Development Online MSc program at Queen Mary University of London. This program is offered in GBR and provides an excellent learning opportunity in Masters studies.

The Clinical Drug Development Online MSc at Queen Mary University of London offers a comprehensive understanding of the drug development process, from discovery to commercialization. This multidisciplinary program is tailored for professionals in the pharmaceutical industry and contract research organizations, equipping them with essential skills for career advancement. The curriculum includes nine compulsory modules covering critical areas such as drug design, clinical trial management, and regulatory affairs, culminating in a 20,000-word dissertation. The program is delivered entirely online, allowing students to study flexibly from anywhere in the world. With options for both full-time (1 year) and part-time (2-4 years) study, it caters to the needs of working professionals. Graduates are well-prepared for roles in clinical trials, pharmaceutical analysis, and drug safety, making this program a valuable asset for those looking to excel in the field of clinical drug development.

University
Queen Mary University of London
University Location
GBR (Online)
Program Duration
1.0 years
Ranking
#120
Part-time allowed
Yes

Required Courses
  • Drug Discovery and Pre-Clinical Research and Development
  • Toxicology: from Molecules to Man
  • Clinical Study Design
  • Practical Aspects of Clinical Research and Early Drug Development
  • Ethics and Regulation in Clinical Research
  • Data Management: the Interpretation of Statistics and Pharmacokinetics
  • Health and Pharmaco-Economics
  • Pharmaceutical and Healthcare Marketing
  • Dissertation
  • Specific Topics in Clinical Trial Design and Elective Project
Elective Courses
  • No elective courses listed.